NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

表纸
市场调查报告书

碎石术用设备的全球市场 - 成长,趋势,预测(2019年~2024年)

Lithotripsy Device Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

出版商 Mordor Intelligence Pvt Ltd 商品编码 910274
出版日期 内容资讯 英文 120 Pages
商品交期: 2-3个工作天内
价格
碎石术用设备的全球市场 - 成长,趋势,预测(2019年~2024年) Lithotripsy Device Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
出版日期: 2021年03月01日内容资讯: 英文 120 Pages
简介

全球碎石术用设备市场,由于尿结石症的罹患率上升,及体外冲击波碎石技术(ESWL)的治疗数量增加,医疗技术的进步等,促进成长。

本报告提供全球碎石术用设备市场调查,市场概要,各类型、用途、终端用户、地区的市场规模的变化与预测,市场成长要素及阻碍因素分析,竞争情形,主要企业的简介等全面性资讯。

目录

第1章 简介

  • 调查成果
  • 调查的前提条件
  • 调查范围

第2章 调查方法

第3章 摘要整理

第4章 市场动态

  • 市场概况
  • 市场成长要素
    • 尿结石症的发生率上升
    • 体外冲击波碎石技术(ESWL)的治疗数量增加
    • 技术进步
  • 市场阻碍因素
    • 碎石术的副作用
    • 替代治疗的存在
  • 波特的五力分析
    • 买方议价能力
    • 供给企业谈判力
    • 新加入业者的威胁
    • 替代品的威胁
    • 竞争企业间的敌对关系

第5章 碎石术用设备市场:各市场区隔

  • 各类型
    • 体外冲击波碎石技术(ESWL)
    • 尿路内碎石术
  • 各用途
    • 肾脏结石
    • 输尿管结石
    • 胰石头
    • 胆管结石
  • 各终端用户
    • 医院
    • 门诊病人手术中心
    • 其他
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 中东、非洲
    • 南美

第6章 竞争情形

  • 企业简介
    • EDAP TMS
    • Electro Medical Systems S.A.
    • Olympus Americas
    • Dornier MedTech
    • DirexGroup
    • Storz Medical AG
    • Lumenis
    • Walz Elektronik GMBH
    • Novamedtek
    • Elmed Medical Systems

第7章 市场机会及未来趋势

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: 64420

The lithotripsy devises market is projected to register a CAGR of 4.3%, during the forecast period, with a revenue of approximately USD 1,580 million in 2020 and expected to reach USD 2,040 million by 2026.

The major factors that are driving the market are primarily driven by the increasing incidence of urolithiasis, rise in the number of extracorporeal shock waves lithotripsy procedures, and technological advancements coupled with rising awareness. The COVID-19 has severely impacted the lithotripsy devices market, as anaesthesiologists were needed to manage the patients in acute COVID-19 crisis and, therefore, had to withdraw from elective surgery. The number of beds used for urological patients had to be reduced to dedicate beds and personnel to the new COVID-19 wards. Also, there was a need to not infect elective patients via hospital contamination. Most importantly, from a urological perspective, most of the residual urological medical staff became entirely dedicated to managing the infected patients on the newly formed COVID-19 ward. Hence, the growing cases of COVID-19 patient pool and lesser number of elective surgeries are anticipated to harm the market in the year 2020.

Urolithiasis is a common urologic problem and it poses a significant burden on the healthcare system, globally. It is associated with an increased risk of end-stage renal failure, which is driving the demand for lithotripsy devices. As per the European Association of Urology, 2019, the prevalence rates for urinary stones vary from 1% to 20%. In countries with a high standard of life, such as Canada, Sweden, or the United States, renal stone prevalence is notably high (> 10%). For some areas, an increase of more than 37% has been reported, over the last 20 years. It has been associated with an increased risk of end-stage renal failure. Thus, the increasing global prevalence of urolithiasis necessitates safe, efficacious, and affordable treatment for urolithiasis.

Over the years, lithotripsy has become the most preferred method for the treatment of kidney stones, largely due to the advantage of its relative safety, low cost, less recovery time, and positive patient outcomes. Thus, all these factors are responsible for driving the growth of the market studied.

However, apart from several advantages of the treatment, there are several risks associated with the lithotripsy treatment. This treatment sometimes leads to internal bleeding and may need a blood transfusion. It can lead to adverse side effects, where the kidney may get damaged due to blockage in the flow of urine passage caused by tiny stone particles. There are complications, such as high blood pressure, which also restrain the market. Also, the adverse effects of lithotripsy shock waves often result in hypertension, diabetes, and, in some cases, permanent loss of functional renal volume, which act as major barriers for the lithotripsy devices market.

Key Market Trends

Extracorporeal Shock Wave Lithotripsy (ESWL) Devices is Expected to Have Significant Share in the Market

Extracorporeal shock wave lithotripsy is a technique for treating stones in the kidney and ureter that do not require surgery. Instead, high-energy shock waves are passed through the body and used to break stones into pieces as small as grains of sand. The Extracorporeal Shock Wave Lithotripsy devices (ESWL) are used for the treatment of kidney and ureter stones. This technology has been utilized by physicians worldwide and is expected to increase its penetration over the coming years due to the advantages offered by such as minimal invasiveness, reduced pain, and shorter hospital stay, and quicker recovery time.

With the growing cases of COVID-19, there is a lesser number of urology surgeries being performed that has also reduced the number of extracorporeal shock wave lithotripsy (ESWL) devices during this time that is anticipated to show a slight negative impact on the market.

It is the most common lithotripsy performed outside the body, which refers to the shock wave treatment. During extracorporeal shock wave lithotripsy (ESWL), a special machine, known as lithotripter, generates high-energy shock waves, such as sound waves, X-ray, or ultrasound, which pass through the body until they hit the kidney stones.

However, it was found that ESWL was first performed in the United States. However, it has been reported that some patients may not experience a successful outcome following ESWL. ESWL, however, is only used in selected stones in the kidney and ureter. Therefore, it does not apply to all stone types or locations. Generally, this procedure is considered safe and less time-consuming, it takes only 45 minutes to perform. The growing demand for non-invasive procedures is leading to the adoption of ESWL.

Hence with the growing kidney-related disorders coupled with rising awareness across the globe likely to augment the market growth over the forecast period.

North America Holds the Largest Share of the Lithotripsy Device Market

In North America, the lithotripsy devices market is projected to have significant market growth over the forecast period. Chronic kidney diseases are estimated to common in women than in men. The number of chronic kidney diseases is found increasing globally. Kidney disease statistics for the United States convey the burden of chronic kidney disease (CKD) and end-stage renal disease (ESRD).

The outbreak of COVID-19 has brought a negative impact on the lithotripsy devices market due to the reduced number of surgeries being performed during the COVID-19 that also resulted in reduced usage of the devices. COVID-19 has also affected the market by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

According to the Centers for Disease Control and Prevention, 2019, there are around 37 million people, i.e., 1 out of every 7, or 15% of the adult population, were estimated to have chronic kidney diseases. With the increasing cases of kidney diseases, over 50,000 lithotripsy procedures are completed annually in the United States, which helps in driving the lithotripsy devices market.

Also in January 2019, Shockwave Medical has launched a US pivotal trial for its coronary lithotripsy device, which is designed to prepare heavily calcified coronary lesions for stenting. This technology uses sonic pressure waves to fracture intimal and medial calcium without damaging arterial tissue, which is likely to expand the company's business and help in driving the lithotripsy devices market in the country.

Hence during the forecast period, the region's share of the global market is likely to grow significantly, owing to the high prevalence and the treatments of kidney stone disease in the United States. Also, product launches, acquisition and collaborations are expected to promote the regional market.

Competitive Landscape

The lithotripsy device market is found to be competitive. The key market players operating in lithotripsy devices are EDAP TMS, Boston Scientific Corporation, Olympus Corporation, Accuron and DirexGroup among others. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships, which help them strengthen their market positions. Furthermore, companies also focusing on the widening applications of lithotripsy devices to strengthen their market over the forecast period.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Burden of Urolithiasis
    • 4.2.2 Rise in Number of Extracorporeal Shock Wave Lithotripsy Procedures
    • 4.2.3 Technological Advancements in Minimally Invasive Surgeries
  • 4.3 Market Restraints
    • 4.3.1 Adverse Effects Associated with Lithotripsy
    • 4.3.2 Availability of Alternative Treatments for Stone Removal
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Extracorporeal Shock Wave Lithotripsy Devices
    • 5.1.2 Intracorporeal Lithotripsy Devices
      • 5.1.2.1 Laser Lithotripsy Devices
      • 5.1.2.2 Electrohydraulic Lithotripsy Devices
      • 5.1.2.3 Ultrasonic Lithotripsy Devices
      • 5.1.2.4 Pneumatic (Ballistic) Lithotripsy Devices
  • 5.2 By Application
    • 5.2.1 Kidney Stones
    • 5.2.2 Ureteral Stones
    • 5.2.3 Pancreatic Stones
    • 5.2.4 Bile Duct Stones
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 EDAP TMS
    • 6.1.2 Electro Medical Systems SA (Boston Scientific Corporation)
    • 6.1.3 Olympus Americas
    • 6.1.4 Dornier MedTech
    • 6.1.5 Becton, Dickinson and Company
    • 6.1.6 Storz Medical AG
    • 6.1.7 Cook Medical LLC
    • 6.1.8 Walz Elektronik GMBH
    • 6.1.9 Novamedtek
    • 6.1.10 Elmed Medical Systems
    • 6.1.11 Karl Storz SE & Co. KG
    • 6.1.12 Siemens Healthineers AG
    • 6.1.13 Richard Wolf GmbH
    • 6.1.14 DirexGroup
    • 6.1.15 Lumenis

7 MARKET OPPORTUNITIES AND FUTURE TRENDS